Yusuf S et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. The Lancet, 2004, 364(9438): 937-952.
Nielsen KM et al. Danish singles have a twofold risk of acute coronary syndrome: data from a cohort of 138 290 persons. Journal of Epidemiology & Community Health, 2006, 60(8): 721-728.
Netterstrøm B, Kristensen TS, Sjøl A. Psychological job demands increase the risk of ischaemic heart disease: a 14-year cohort study of employed Danish men. European Journal of Cardiovascular Prevention & Rehabilitation, 2006, 13(3): 414-420.
Юнусова С.Г., Розенталь А.Н., Балтина Т.В. Стресс. Биологический и психологический аспекты. Ученые записки Казанского университета. Серия Гуманитарные науки, 2008, 150(3).
Барковская А.Ю., Назарова М.П. Стресс-факторы в социокультурном пространстве современного большого города. Primo Aspectu, 2014, 16(5): 37-42.
Kino T, Charmandari E, Chrousos GP. Disorders of the Hypothalamic-Pituitary-Adrenocortical System. Handbook of Neuroendocrinology, 2012: 639-657.
Шастун С.А., Агаджанян Н.А., Игнатьев А.В. Особенности процессов свободно-радикального окисления крови у людей с различным уровнем физической работоспособности. Вестник РУДН. Серия: Медицина, 2002, 3.
Eiden LE. Neuropeptide-catecholamine interactions in stress. Advances in Pharmacology. Academic Press, 2013, 68: 399-404.
Оганов Р.Г., Погосова Г.В. Стресс: что мы знаем сегодня об этом факторе риска? Рациональная фармакотерапия в кардиологии, 2007, 3(30).
Larzelere MM, Jones GN. Stress and health. Primary Care: Clinics in Office Practice, 2008, 35(4): 839-856.
Воробьева О.В. Стресс и расстройства адаптации. РМЖ, 2009, 17(11): 789-793.
Громова О. А. и др. Дефицит магния как проблема стресса и дезадаптации у детей. РМЖ, 2012, 20(16): 813-821.
Landfield PW et al. A new glucocorticoid hypothesis of brain aging: implications for Alzheimer’s disease. Current Alzheimer Research, 2007, 4(2): 205-212.
Parati G, Molinary E. Clinical psychology and heart disease. 2010.
Tamashiro KL et al. Chronic stress, metabolism, and metabolic syndrome. Stress, 2011, 14(5): 468-474.
Dhabhar FS. Effects of stress on immune function: the good, the bad, and the beautiful. Immunologic research, 2014, 58(2-3): 193-210.
Sharpe KH et al. Association between socioeconomic factors and cancer risk: a population cohort study in Scotland (1991-2006). PLoS One, 2014, 9(2): e89513.
Drossman DA. Functional gastrointestinal disorders: history, pathophysiology, clinical features, and Rome IV. Gastroenterology, 2016, 150(6): 1262-1279.
Steptoe A, Kivimäki M. Stress and cardiovascular disease. Nature Reviews Cardiology, 2012, 9(6): 360.
Lampert R. Mental stress and ventricular arrhythmias. Current cardiology reports, 2016, 18(12): 118.
Richman LS et al. The relationship between mental vitality and cardiovascular health. Psychology and Health, 2009, 24(8): 919-932.
Оганов Р.Г. и др. Значение сердечно-сосудистых и других неинфекционных заболеваний для здоровья населения России. Профилактическая медицина, 2002, 5(2): 3-7.
Rozanski A, Blumenthal JA, Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation, 1999, 99(16): 2192-2217.
Hansson A, Madsen-Härdig B, Olsson SB. Arrhythmia-provoking factors and symptoms at the onset of paroxysmal atrial fibrillation: a study based on interviews with 100 patients seeking hospital assistance. BMC cardiovascular disorders, 2004, 4(1): 13.
Cohen BE et al. Psychological risk factors and the metabolic syndrome in patients with coronary heart disease: findings from the Heart and Soul Study. Psychiatry research, 2010, 175(1): 133-137.
Kiecolt-Glaser JK et al. Chronic stress and age-related increases in the proinflammatory cytokine IL-6. Proceedings of the national Academy of Sciences, 2003, 100(15): 9090-9095.
Mocci F et al. The effect of noise on serum and urinary magnesium and catecholamines in humans. Occupational Medicine, 2001, 51(1): 56-61.
Grases G et al. Anxiety and stress among science students. Study of calcium and magnesium alterations. Magnesium research, 2006, 19(2): 102-106.
Jacka FN et al. Association between magnesium intake and depression and anxiety in community-dwelling adults: the Hordaland Health Study. Australian & New Zealand Journal of Psychiatry, 2009, 43(1): 45-52.
Billyard AJ, Eggett DL, Franz KB. Dietary magnesium deficiency decreases plasma melatonin in rats. Magnesium research, 2006, 19(3): 157-161.
Abbasi B et al. The effect of magnesium supplementation on primary insomnia in elderly: A double-blind placebo-controlled clinical trial. Journal of research in medical sciences: the official journal of Isfahan University of Medical Sciences, 2012, 17(12): 1161.
Werbach MR. Nutritional strategies for treating chronic fatigue syndrome. Alternative Medicine Review, 2000, 5(2): 93-108.
Takaya J, Higashino H, Kobayashi Y. Intracellular magnesium and insulin resistance. Magnesium research, 2004, 17(2): 126-136.
Nielsen FH. Magnesium, inflammation, and obesity in chronic disease. Nutrition reviews, 2010, 68(6): 333-340.
Guerrero‐Romero F, Rodríguez‐Morán M. Hypomagnesemia, oxidative stress, inflammation, and metabolic syndrome. Diabetes/metabolism research and reviews, 2006, 22(6): 471-476.
Maier JAM et al. Low magnesium promotes endothelial cell dysfunction: implications for atherosclerosis, inflammation and thrombosis. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, 2004, 1689(1): 13-21.
Takase B et al. Effect of chronic stress and sleep deprivation on both flow‐mediated dilation in the brachial artery and the intracellular magnesium level in humans. Clinical cardiology, 2004, 27(4): 223-227.
Champagne CM. Magnesium in hypertension, cardiovascular disease, metabolic syndrome, and other conditions: a review. Nutrition in Clinical Practice, 2008, 23(2): 142-151.
Gums JG. Magnesium in cardiovascular and other disorders. American journal of health-system pharmacy, 2004, 61(15): 1569-1576.
De Lenardis M, Schindler R, Classen HG. Hypomagnesemia and suboptimal plasma-Mg levels in diabetes mellitus: frequencies and consequences. Magnesium-bulletin, 2000, 22(3): 53-59.
Калачева А. Г. Элемент-специфические инди-каторы нейротропных функций магния. Москва, 2011. С. 23./ Kalacheva AG. Element-specific indicators of neurotropic functions of magnesium. Moscow, 2011. P. 23.
Hänni A. Magnesium and the insulin resistance syndrome: дис. Acta Universitatis Upsaliensis, 2001.
Held K et al. Oral Mg2+ supplementation reverses age-related neuroendocrine and sleep EEG changes in humans. Pharmacopsychiatry, 2002, 35(04): 135-143.
Калинин В.В. и др. Применение препарата Магне-В6 для лечения тревожно-депрессивных состояний у больных эпилепсией. Журнал неврологии и психиатрии им. C.C. Корсакова, 2004, 104(8): 51-55.
Вейн А.М., Соловьева А.Д., Акарачкова Е.С. Магне В6 в лечении синдрома вегетативной дистонии. Лечение нервных болезней, 2003, 4(2): 10.
Громова О.А. и др. Молекулярные механизмы действия пидолата магния и его нейротропные эффекты. Журнал нейрологии и психиатрии, 2016, 12: 96-103.